PB-119 injection

BIOLOGICAL3 trials

Sponsors

PegBio Co., Ltd.

Conditions

Type II Diabetes MellitusType2 Diabetes Mellitus

Phase 1

Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus

CompletedNCT03059719

PegBio Co., Ltd.Type II Diabetes Mellitus

Start: 2015-04-08End: 2016-10-27Updated: 2017-02-23

Continuous Multiple Dose PB-119 Injection in Health Volunteers

CompletedNCT03062774

PegBio Co., Ltd.Type2 Diabetes Mellitus

Start: 2014-11-15End: 2016-10-08Updated: 2017-02-23

MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM

CompletedNCT03072407

PegBio Co., Ltd.Type2 Diabetes Mellitus

Start: 2015-11-24End: 2016-11-15Updated: 2018-04-20

Related Papers

Safety, Pharmacokinetics and Pharmacodynamics of Multiple Escalating Doses of PEGylated Exenatide (PB-119) in Healthy Volunteers.

2021-02-123 citations